Vetter
Vetter has announced the release of its Vetter-Ject prefilled syringe closure system for highly-sensitive compounds such as biologics. The tamper-evident closure system, combined with an integrated staked needle, supports product integrity.
Pharmaceutical and biotech companies are increasingly developing drugs that incorporate sensitive and complex compounds. An injection system that can be used flexibly while being safe and simple to handle, the Vetter-Ject consists of a needle hub and shield and is partly produced by means of a two-component injection moulding process of polypropylene and thermoplastic elastomer.
Vetter-Ject is ready-to-use with an integrated needle that is simple to handle and user-friendly. The tamper-evident closure means that any attempt at opening of the closure system will be immediately and permanently visible to the naked eye. This product attribute is activated when the needle shield is removed and plastic bridges are broken, preventing any potential misuse or reuse.
Vetter-Ject can be used with a wide range of primary packaging options such as different stoppers and glass barrels, which can be customised depending on the drug product. Moreover, Vetter provides complete sterile fill and finish services and offers, as part of its packaging service, the assembly and final packaging of Vetter-Ject syringe systems.
Vetter's new syringe closure system has already been the recipient of two international awards prior to its launch: the IF Design Award and the Red Dot Design Award.